Medication Treatment for Picking and Pulling in Vascular Dementia
For compulsive picking and pulling behaviors in vascular dementia, initiate a selective serotonin reuptake inhibitor (SSRI) such as fluvoxamine or citalopram as first-line pharmacological treatment, only after attempting nonpharmacological interventions and when symptoms are severe enough to cause significant distress or safety concerns.
Treatment Algorithm
Step 1: Nonpharmacological Interventions First
Before any medication, you must attempt nonpharmacological strategies unless the behavior poses imminent danger 1, 2. These compulsive behaviors often stem from unmet needs or environmental triggers that can be modified 1. This is the standard of care endorsed by the American Geriatrics Society and American Psychiatric Association 1, 2.
Step 2: When to Consider Medication
Pharmacological treatment is appropriate only when 2:
- Symptoms are severe, dangerous, or cause significant patient distress
- Nonpharmacological interventions have been inadequate
- The behavior creates safety risks (e.g., skin infections from picking, self-injury)
Step 3: First-Line Pharmacological Choice
SSRIs are the primary medication class for compulsive picking and pulling behaviors:
- Fluvoxamine showed specific efficacy in a case of frontotemporal dementia with skin-picking compulsion 3, and SSRIs demonstrate the most promising results for skin-picking disorder overall 4
- Citalopram is supported for behavioral symptoms in dementia with a favorable safety profile 5
- Start at low doses and titrate to minimum effective dose 2
Step 4: Augmentation Strategy if SSRI Alone Insufficient
Add topiramate if SSRI monotherapy provides inadequate response. The combination of fluvoxamine plus topiramate successfully treated skin-picking compulsion in a documented dementia case 3. This augmentation strategy addresses both serotonergic and glutamatergic mechanisms.
Step 5: Alternative Options
If SSRIs are contraindicated or ineffective:
- N-acetylcysteine (glutamatergic modulator) is well-established for skin-picking disorder 4
- Naltrexone (opioid antagonist) has evidence in skin-picking disorder 4
Critical Caveats
Avoid antipsychotics for these specific symptoms. While antipsychotics are sometimes used for agitation in dementia, they show only modest efficacy for neuropsychiatric symptoms generally 1 and carry significant risks including increased mortality 1. Picking and pulling behaviors are better conceptualized as compulsive/impulsive phenomena rather than psychotic or aggressive agitation, making SSRIs more mechanistically appropriate 4, 3.
Monitoring and Duration
- Assess response with quantitative measures 2
- Allow 4 weeks at adequate dose before declaring treatment failure 2
- If no response after 4 weeks, taper and discontinue 2
- If effective, periodically reassess need for continuation with patient/family discussion 2
- Monitor for SSRI side effects (hyponatremia, falls, GI symptoms) particularly in older adults
Key Distinction
The evidence specifically addresses picking/pulling as compulsive behaviors rather than general agitation. This distinction is crucial because it shifts treatment away from antipsychotics (which dominate dementia agitation guidelines 1, 2) toward medications targeting obsessive-compulsive spectrum symptoms 4, 3.